24 October, 2022

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, Pedro Plazuelo-Ramos, Dale Webb, Clare Jacklin, Shantel Irwin, Laurent Grange, Souzi Makri, Elsa Frazão Mateus, Serena Mingolla, Katy Antonopoulou, Sergio Sanz-Gómez, José Correa-Fernández,…

Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas

Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas Pablo Irimia, Marco Garrido-Cumbrera, Sonia Santos-Lasaosa, Marta Aguirre-Vazquez, José  Correa-Fernández, Isabel Colomina and Patricia Pozo-Rosich Scientific Reports. 2021 Objective Identifying highly disabled patients or at high risk of psychiatric comorbidity is crucial for migraine management. The burden…

Estimating the savings associated with a migraine-free life: results from the Spanish Atlas

Estimating the savings associated with a migraine-free life: results from the Spanish Atlas Pablo Irimia, Marco Garrido-Cumbrera, Sonia Santos-Lasaosa, Olta Braçe, Isabel Colomina, Carles Blanch, Patricia Pozo-Rosich Eur J Neurol. 2020 Objective Migraine is a common and costly neurological disorder. The aims of this study were to quantify the costs of chronic (CM) and episodic…